Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Plans Limited Use Of “Coverage With Evidence Development” Option

Executive Summary

The Centers for Medicare & Medicaid Services plans to require data collection as a condition of product coverage only in rare circumstances

You may also be interested in...



CMS To Give More Specifics For Use Of Coverage With Evidence Development

The Centers for Medicare & Medicaid Services will offer greater clarity on when it will require data collection as a condition of Medicare Part B coverage in a second draft of its guidance on the topic

CMS To Give More Specifics For Use Of Coverage With Evidence Development

The Centers for Medicare & Medicaid Services will offer greater clarity on when it will require data collection as a condition of Medicare Part B coverage in a second draft of its guidance on the topic

Part B “Evidence Development” Plan Needs Defined Scope – Manufacturers

The Centers for Medicare & Medicaid Services needs to more clearly define the circumstances for applying a determination of coverage with evidence development for Medicare Part B-covered drugs, BIO and PhRMA say in comments on a draft guidance

Related Content

Topics

UsernamePublicRestriction

Register

LL1133951

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel